ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 82 filers reported holding ADICET BIO INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,205 | -57.8% | 1,319 | 0.0% | 0.00% | – |
| Q1 2023 | $7,597 | -59.6% | 1,319 | -37.3% | 0.00% | -100.0% |
| Q4 2022 | $18,810 | -13.1% | 2,104 | +38.1% | 0.00% | 0.0% |
| Q3 2022 | $21,657 | -2.6% | 1,523 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $22,236 | -26.9% | 1,523 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $30,414 | -71.4% | 1,523 | -75.0% | 0.00% | 0.0% |
| Q4 2021 | $106,339 | – | 6,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $42,160,000 | 11.96% |
| Foresite Capital Management V, LLC | 680,000 | $13,580,000 | 5.55% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $3,395,000 | 4.75% |
| Tri Locum Partners LP | 523,256 | $10,449,000 | 4.08% |
| DAFNA Capital Management LLC | 715,872 | $14,296,000 | 3.72% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $11,583,000 | 3.55% |
| COWEN AND COMPANY, LLC | 1,500,055 | $29,956,000 | 2.88% |
| JOHNSON & JOHNSON | 728,944 | $14,557,000 | 2.75% |
| Orbimed Advisors | 7,447,141 | $148,719,000 | 2.41% |
| Ikarian Capital, LLC | 507,348 | $10,132,000 | 1.33% |